tiprankstipranks
The Fly

Heron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M

Heron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M

Consensus for 2024 revenue is $148.4M. Raises 2024 adjusted EBITDA view to $2M-$5M from (22M)-$3M.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com